Codexis, Inc. (CDXS) vs Minerva Neurosciences, Inc. (NERV)
A side-by-side comparison of Codexis, Inc. and Minerva Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDXS
Codexis, Inc.
$1.42HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
NERV
Minerva Neurosciences, Inc.
$3.37HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
Total return — CDXS vs NERV
growth of $100 · dividends reinvested · last 10yCDXS -68.6% (-10.9%/yr)NERV -97.0% (-29.7%/yr)CDXS compounded faster over this window
Log scale — wide-divergence pair
CDXS NERV
CDXS vs NERV: by the numbers
- •NERV is the larger company ($157M vs $153M market cap).
- •Both run net losses; NERV's is the smaller (0.00% vs -39.55% net margin).
Metrics side by side
Valuation
| Metric | CDXS | NERV |
|---|---|---|
| P/S ratio | 1.97 | N/A |
| P/B ratio | 4.63 | N/A |
Profitability
| Metric | CDXS | NERV |
|---|---|---|
| Gross margin | 83.71% | 0.00% |
| Operating margin | -54.46% | 0.00% |
| Net margin | -39.55% | 0.00% |
| ROE | -93.22% | N/A |
| ROIC | -23.41% | -38.56% |
Growth (annualized)
| Metric | CDXS | NERV |
|---|---|---|
| Revenue CAGR (5Y) | 0.38% | N/A |
| Total return CAGR (5Y) | -44.64% | -22.14% |
Frequently asked
- How have CDXS and NERV total returns compared?
- Over the past 10 years, CDXS delivered -11.05% and NERV delivered -29.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.